Press Release: Seventh Asia Pac Pharma and Medical Device Compliance Congress Early Bird Registration Discount Ends Friday; C-suite Featured
  • Sponsored by Asia Pacific Healthcare Industry Compliance Team
  • Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
  • September 13 - 15, 2017
  • InterContinental Shanghai, Shanghai, China
  • www.AsianPharmaCongress.com

PRESS RELEASE
Phone: 800-503-6498
Email: registration@hcconferences.com
Website: www.AsianPharmaCongress.com
FEATURING THE ROLE OF LEADERSHIP IN THE SUCCESS OF ETHICS AND COMPLAINCE PROGRAMS BY
Hervé Gisserot, Senior Vice President and Head of Pharmaceuticals Asia Pacific, GlaxoSmithKline, Former Senior Vice President and General Manager of Pharmaceuticals and Vaccines, GlaxoSmithKline (China), Former President, Leem, Singapore
Jean-Christophe Pointeau, PhD, Country Chair, Sanofi China, Board Member, JHL Biotech, Former President, China, Bristol-Myers Squibb, Shanghai, China
AGENDA AND BROCHURE
NOW AVAILABLE
Click here to view the agenda.
Click here to view the brochure.
EARLY BIRD REGISTRATION
- SAVE UP TO $600 -
Register by Friday, July 28, 2017 and save up to $600. Click here to register.

SHANGHAI, CHINA -- PHARMA UPDATE NEWS SERVICE™ -- JULY 25, 2017: The Seventh Asia Pacific Pharmaceutical and Medical Device Compliance Congress, www.AsianPharmaCongress.com, will be held September 13 - 15, 2017 at the InterContinental Shanghai in Shanghai, China.





KEYNOTE SPEAKERS

Mike Dethick, LLB
Managing Director, R&D-Based Pharmaceutical Association Committee, Beijing, China

Luca Genovese, AMID
Researcher, Access to Medicine Foundation, Amsterdam, Netherlands

Hervé Gisserot
Senior Vice President and Head of Pharmaceuticals Asia Pacific, GlaxoSmithKline, Former Senior Vice President and General Manager of Pharmaceuticals and Vaccines, GlaxoSmithKline (China), Former President, Leem, Singapore

Kent Kedl, MA
Senior Partner, Control Risks, Former Vice President and General Manager, Technomic Asia, Shanghai, China

George "Ren" McEachern, CFE, CAMS
Supervisory Special Agent, International Corruption Squad, US Federal Bureau of Investigation, Washington, DC, USA

Jean-Christophe Pointeau, PhD
Country Chair, Sanofi China, Board Member, JHL Biotech, Former President, China, Bristol-Myers Squibb, Shanghai, China

Michael Thun, MBA
Senior Expert, McKinsey & Company, Inc., Former Global Chief Ethics & Compliance Officer, Boehringer Ingelheim, Former Chief Compliance Officer, Ferrostaal AG, Former Head of Compliance Europe, Siemens AG, Munich, Germany

Christopher L. White, JD
Chief Operating Officer General Counsel, Advanced Medical Technology Association (AdvaMed), Washington, DC, USA

Professor Huang Yong
Competition Law Center, University of International Business and Economics, Executive Vice Chair, Expert Consultation Group, Anti-Monopoly Committee, State Council, Peoples Republic of China, Beijing, China

CO CHAIRS

Masood Ahmed
Vice President, Regional Compliance Officer Asia & JPAC, Sanofi Group, Singapore

Maija Burtmanis, LLB/BSc LLM
Regional Compliance Director, Japan / Asia Pacific, Shire, Former Healthcare CO, Asia Pacific Medical Sciences, Johnson & Johnson, Singapore

Gareth Lee
Vice President, Legal and Compliance, Asia Pacific, Cardinal Health, Former General Counsel & Head of Compliance, Asia Pacific, Allergan, Singapore

Maria “Maru” Quindimil, MBA
APAC Ethics and Compliance Lead, UCB Pharma, Former Executive Director, Regional Compliance Officer, Asia Pacific and India, Merck Sharp and Dohme (Asia Ltd.), Shanghai, China

Rhys Tee
Director, Compliance and Privacy, ASPAC, Ortho Clinical Diagnostics, Former Compliance Director, Asia, Abbott Laboratories (Singapore) Pte. Ltd., Former Associate Director, Compliance (APAC), Allergan, Singapore

FEATURING A PRECONFERENCE
  • Training in Compliance and Ethics Basics

PLENARY SESSIONS
  • Keynote: Hervé Gisserot, SVP and Head of Pharmaceuticals, Asia Pacific, GSK
  • Keynote: Jean-Christophe Pointeau, PhD, Country Chair, Sanofi China
  • Keynote: Prof Huang Yong, Competition Law Center, Univ of Int'l Business and Economics
  • Keynote: George "Ren" McEachern, CFE, CAMS, Supervisory Special Agent, FBI
  • Global Chief Compliance Officer Roundtable
  • Managing Pharma & Device Risk Across the Asia Pacific Region
  • Asia Pac Anticorruption Update Roundtable
  • Asia Pac Public-Private Pharmaceutical Partnerships
  • The Chinese Anti-unfair Competition Law
  • RDPAC Pharmaceutical Enterprise Ethical Business Practice
  • AdvaMed'S Code of Ethics on Interactions with HCPs in China
  • The Continued Evolution of Compliance as a Profession
  • Pharmaceutical Compliance and Access to Medicine
  • Roundtable on New Directions in Compliance Innovation
AND MINI SUMMITS
  • Chinese Anticorruption and Compliance Best Practices Roundtable
  • Asia Pac Medical Device Compliance Regulatory Developments and Burning Issues
  • Separation and Collaboration between Medical Education and Product Promotion
  • Organizational Justice: One of the Pillars of a Culture of Integrity
  • Transparency Reporting to Prevent Corruption Risk
  • How to Eliminate Anti-Corruption Risks for Tier 2 and Tier 3 Cities and Mobile Offices
  • Korean Anticorruption and Compliance Best Practices Roundtable
  • Global Data Privacy Update and the Impact to the Life Sciences Industry
  • The Art of the Investigation: Planning, Executing and Completing Investigations
  • The Evolution of Compliance Organizations
  • Third Party Management, including Due Diligence, Contracting, Monitoring and Payment
  • When Will You Deploy Robot(s) in your Compliance Team?
  • Compliance and Ethical Issues in Patient Support Programs and Patient Advocacy Organizations
  • Fraud Trends in Asia Pacific and How Companies are Dealing with Them

FEATURED FACULTY

Ted Acosta, Esq.
Americas Vice Chair, Risk Management, EY, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France

Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY, USA

M. Jason Brooke, JD
Director, Healthcare and Life Sciences Disputes, Regulatory, Compliance, and Investigations, Navigant, Former Board Member and General Counsel, Vasoptic Medical, Inc., Washington, DC

Brian Caster, JD
Regional Compliance Investigations Lead, Pfizer, Tokyo, Japan

Eric Carlson, JD
Partner, Covington & Burling LLP, Shanghai, China

Stacy Chai
Partner, Fraud Investigation & Dispute Services, EY, Singapore

Praween Chantanakomes, JD
Associate, Baker & McKenzie, Bangkok, Thailand

Chi Chen
Fraud Investigation & Dispute Services, EY, Shanghai, China

Vivian Chen, LLB
Head of Compliance, Alcon Laboratories China, A Novartis Division, Former Head of Ethic and Compliance, Greater China, Baxter Intl Inc., Beijing, China

Steven Chon, MA
Director, Fraud Investigation & Dispute Services (Hong Kong & Korea), EY, Hong Kong

Hwa Soo Chung, JD, MPA
Chair, Health Practice Group, Kim and Chang, Seoul, South Korea

Campbell Clark, LLB, MJ
Chief Ethics and Compliance Officer, Asia Pacific, Medtronic, Covidien Private Limited, Chair, Legal, Ethics and Compliance Committee, Asia Pacific Medical Technology Association (APACMed), Singapore

Karen Eryou
Head, Ethics AND Compliance Programs, UCB Pharma, Former Co-chair, Asia Pacific Pharma Compliance Congress, Brussels, Belgium

Giuseppe Falbo
Regional Compliance Director (APAC and Russia), Alcon, A Novartis Division, Former Business Practices Officer (Asia, Middle East, Africa, Latin America), Novartis International AG, Singapore

J. Mark Farrar, CPA, CFE, CFF
Healthcare and Life Sciences Disputes, Regulatory, Compliance and Investigations, Navigant, Former Interim Global Chief Compliance Officer, Beckman Coulter, Atlanta, GA, USA

Chris Fordham
Managing Partner, Asia Pacific Area, Fraud Investigation, and Dispute Services, EY, Hong Kong

Mohit Grover
Executive Director, Risk Consulting, Deloitte; Former Regional Chief Information Officer, Astra Zeneca Asia Pacific, Singapore

Winnie Ho
Partner, Fraud Investigation & Dispute Services, EY, Hong Kong and Shanghai, China

Ewa Holker
Legal & Compliance Director (APAC), Ferring Pharmaceuticals, Former Director, Legal & Compliance, Asia Pacific, Zimmer Biomet, Singapore

Christine Hu, LLM
Legal and Compliance Director, Medtronic Kanghui Orthopedics, Former Legal, Compliance & Government Affair Director, Zimmer, Beijing, China

Vanessa Han Jun
Head of Compliance, China, Novo Nordisk, Shanghai, China

Jasmine Karimi, LLB
Senior Director & Counsel, APAC, Illumina, Singapore

Yota Kikuchi
Director, Compliance Rules & Management, Japan Pharma Business Unit, Takeda Pharmaceuticals, Member, Code Compliance Committee, Japan Pharmaceutical Manufacturers Association, Member, IFPMA Ethics & Business Integrity Committee (eBIC), Tokyo, Japan

Sarah Kochling
Managing Principal, Blossom Innovation, Board of Directors, American Chamber of Commerce, Shanghai, Shanghai, China

Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA

Patrik Kronig
Head of Compliance Pharma Asia Pacific, Roche, Singapore

David Kurlander, MBA
Vice President, Health Care Compliance, Privacy, FCPA, Ortho Clinical Diagnostics, Former Finance Director, Tax and Commercial Compliance, Ethicon, A Johnson and Johnson Company, New York, NY, USA

Rachel B. Layburn, MBA
Partner in Charge, Forensic and Investigations Practice, KPMG China, Beijing, China

Lei Li, LLM
Partner, Sidley Austin, Former Third Secretary, Ministry of Commerce, People's Republic of China, Beijing, China

Howard Lin
Vice President, Ethics & Compliance - Lilly China, Eli Lilly and Company, Hong Kong

Michael K. Loucks, JD
Partner, Skadden Arps LLP, Former Acting United States Attorney, District of Massachusetts, US Department of Justice, Washington, DC, USA

Albert van Maaren, MSc
Regional Compliance Officer APAC, Group Compliance, Merck Pte. Ltd., Singapore

Christine Ng
Compliance Officer, China, GSK, Shanghai, China

Jennie Orrico, JD
Senior Vice President, Chief Compliance and Risk Officer, Shire, Vice President and Associate General Counsel, Compliance, Baxalta Incorporated, Chicago, IL, USA

Katrina Reinhardt, JD
Regional Head Ethics and Compliance, Asia Pacific, Baxter Healthcare, Former Governance and Compliance Director, Greater China, Dow Corning, Singapore

Redentor Romero, JD
Associate Director, Global Third Party Compliance Program, Takeda Pharmaceuticals International, Former Regional Compliance Officer, Teva Pharmaceuticals, Former Regional Legal Counsel, AstraZeneca, Singapore

Sandeep Seth, LLB
Director, Corporate Compliance, Pfizer India, Former Director, Compliance, India, Sri Lanka, Bangladesh, Pakistan and Nepal, MSD Pharmaceuticals, Mumbai, India

Clarissa Shen
Country Compliance Officer, Sanofi China, Former Associate Compliance, Director, Eli Lilly China, Shanghai, China

Sabina Sudan, LLB, LLM
ECLS-Consults (Ethics/Compliance/Legal/ Sustainability), Legal/International Compliance and Risk Management Professional, Former Vice President and Compliance Officer, Pharma, EJEMAP, GSK, Former Director, Compliance, APAC, Abbott Labs, Singapore and Delhi, India

John Tan, JD
Partner, ReedSmith, Former China Regional Compliance Director, Pfizer, Shanghai, China

Geeta Thakerar
Legal AND Compliance consultancy professional (Asia Pacific), Former Vice President and Associate General Counsel, Asia Pacific/Japan, GlaxoSmithKline plc, Singapore

Yuet Ming Tham, JD
Partner, Sidley Austin LLP, Former Asia Pacific Regional Compliance Director, Pfizer, Former Deputy Public Prosecutor, Singapore, Hong Kong

John Tsai
Forensic Partner, Fraud Investigation & Dispute Services, EY, Shanghai, China

Mini vandePol, LLB
Attorney and Chair, Global Compliance and Investigations Group, Baker McKenzie, Hong Kong

Jonathan Shun Wah, PCLL
Senior Director, China Investigations Team Lead, Pfizer, Hong Kong

YanXiang (Michael) Wang, MBA
Country Director, China, PATH, Former Commercial Development Director, China, Becton Dickinson, Former Area Sales Manager, China, Boehringer Ingelheim, Former Area Assistant Manager, China, GlaxoSmithKline, Beijing, China

Chae Sing Wong
Former Head of Regional Compliance (APAC, MEA, LATM), Mundipharma Pte Ltd, Former Compliance Director, Asia, ANZ and Japan, Baxalta, Former Compliance Director Asia Area, AstraZeneca, Singapore

Joyce Wong
Managing Director, Polaris Asia-Pacific, Former General Manager, Eli Lilly Asia Inc., Hong Kong

Carol Wu
Third Party Audit, Asia, Global Ethics & Compliance, GSK, Former Manager, Ethics & Compliance- China, Hospira, Former Senior Compliance Manager, AstraZeneca, Shanghai, China

Pete (Lijun) Wu, MS, MBA
Chief Compliance Officer, Novartis (Group) China, Shanghai, China

Vivian Wu, LLB, LLM
Counsel, Fenxun Partners, Former Partner, Baker McKenzie, Beijing, China

Vivian Xing, LLB, LLM
Regional Counsel, Danaher Diagnostics Platform, Former Assistant General Counsel, Greater China, Beckman Coulter, Former Regional Counsel Asia Pacific, Eastman Chemical Company, Shanghai, China

Chen Yang, LLB, LLM
Partner and Head, China Life Sciences Practice, Sidley Austin LLP, Former Legislative Official, Bureau of Legislative Affairs, Chinese State Council, Beijing, China

Henry Yao, MA
Head of Compliance, Roche Diagnostics, Asia Compliance Leader, GE Energy Management, Shanghai, China

Xi Zhang, LLM, PhD Law
Vice President & General Counsel Greater China, Bayer (China) Limited, Former General Counsel Asia, Celanese, Shanghai, China

Mike Zhao, MBA
Ethics and Compliance Lead, China, UCB, Former Compliance Manager, Johnson & Johnson, Shanghai, China

2017-2018 GLOBAL PHARMA COMPLIANCE CONGRESSES

ELEVENTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Cosponsored by Pharmaceutical Compliance Forum (PCF)
May 15 - 17, 2017
Lisbon Marriott Hotel
Lisbon, Portugal
www.International PharmaCongress.com
SEVENTH ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
September 13 - 15, 2017
InterContinental Shanghai, Shanghai, China
www.Asian PharmaCongress.com
EIGHTEENTH ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum (PCF)
November 6 - 8, 2017
Mandarin Oriental
Washington, DC
www.PharmaCongress.com


INDIAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
International Society of Healthcare Compliance Professionals (ETHICS)
Cosponsored by International Society of Healthcare Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
Spring 2018
Mumbai, India
Coming Soon


SIMULTANEOUS CHINESE / ENGLISH TRANSLATION OFFERED
And the Following Sessions Offered in Chinese:
  • Chinese Anticorruption and Compliance Best Practices Roundtable
  • How to Eliminate Anti-Corruption Risks for Tier 2 and Tier 3 Cities and Mobile Offices
SPONSORED BY:


The Asia Pacific Healthcare Industry Compliance Team is an ad hoc, voluntary group of Asia Pacific pharmaceutical, medical device and other life sciences company compliance professionals and legal counsel who meet quarterly to discuss legal and compliance issues and best practices.

COSPONSORED BY:

The International Society of Healthcare Ethics and Compliance Professionals (ETHICS) is a forum for open dialogue and exchange among Compliance and Ethics professionals in the Healthcare industry. Association's activities are developed around the four following pillars, sustained by one transverse and permanent objective: support professionals in Compliance and Ethics in Healthcare industry to develop and better manage their role and duties -- without any sort of commercial benefit for the Association or any of its members.



The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 70 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.

GRANTORS:
DIAMOND


BRONZE










MEDIA PARTNER:


CONTINUING EDUCATION CREDITS:
Accounting Professionals: Approved for up to 19.0 NASBA CPE credits.

Compliance Professionals: Pending approval for Compliance Certification Board CCB credits.

Attorneys: Pending approval for Pennsylvania MCLE credits.

Click here for more information.

STAY CONNECTED




Tweet using #PharmaCongress

SEVENTH ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE ETHICS AND COMPLIANCE CONGRESS PLANNING COMMITTEE
CO-CHAIRS

Masood Ahmed
Vice President, Regional Compliance Officer Asia & JPAC, Sanofi Group, Singapore

Maija Burtmanis, LLB/BSc LLM
Regional Compliance Director, Japan/Asia Pacific, Shire, Former Healthcare CO, Asia Pacific, Medical Sciences, Johnson & Johnson, Former Associate GC, Alcon Russia, Former Asia Pacific, Country CO, Novartis SG, Singapore

Gareth Lee
Vice President, Legal and Compliance, Asia Pacific, Cardinal Health, Former General Counsel & Head of Compliance, Asia Pacific, Allergan, Singapore

Maria "Maru" Quindimil, MBA
APAC Ethics and Compliance Lead, UCB Pharma, Former Executive Director, Regional Compliance Officer, Asia Pacific and India, Merck Sharp and Dohme (Asia Ltd.), Shanghai, China

Rhys Tee
Director, Compliance and Privacy, ASPAC, Ortho Clinical Diagnostics, Former Compliance Director, Asia, Abbott Laboratories Pte. Ltd., Former Associate Director, Compliance (APAC), Allergan, Singapore

MEMBERS

Timothy Ayers, JD, MPH
Vice President, Chief Compliance Officer, Horizon Pharma PLC, Executive Committee, Pharmaceutical Compliance Forum, Former VP and CCO, Dendreon, Former Associate GC and ED of Compliance, Seattle Genetics, Chicago, IL, USA

Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY, USA

Tom Chan, JD, LLM
Head of Legal, Greater China, Takeda (China) Holdings Co., LTD, Shanghai, China

Campbell Clark
Chief Ethics and Compliance Officer, Asia Pacific, Medtronic, Covidien Private Limited, Singapore

Abigail Enriquez
Assistant Business Development Manage, Baker & McKenzie, Manilla, Philippines

Karen Eryou
Head, Ethics and Compliance Programs, UCB Pharma, Former Co-chair, Asia Pacific Pharma Compliance Congress, Brussels, Belgium

Michael B. Dusseau
Vice President, Compliance Operations, Allergan plc, Divisional Compliance Officer, Merck, Former Compliance Officer, Schering-Plough, Parsippany, NJ

Giuseppe Falbo
Regional Compliance Director (APAC and Russia), Alcon, A Novartis Division, Former Business Practices Officer (Asia, Middle East, Africa, Latin America), Novartis International AG, Singapore

Ewa Holker
Legal & Compliance Director (APAC), Ferring Pharmaceuticals, Former Director, Legal & Compliance, Asia Pacific, Zimmer Biomet, Singapore

Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA

Patrik Kronig
Head of Compliance Pharma Asia Pacific, Roche, Singapore

Lei Li, LLM
Partner, Sidley Austin, Former Third Secretary, Ministry of Commerce, People's Republic of China, Beijing, China

Howard Lin
Vice President, Ethics & Compliance – Lilly China, Eli Lilly and Company, Hong Kong

Chris Royal
Vice President, Ethics and Compliance Officer Asia Pacific, China and Japan, GSK, Shanghai, China

Sabina Sudan, LLB, LLM
Legal/International Compliance and Risk Management Professional (Singapore / New Delhi, India), Former Vice President and Compliance Officer, Pharma, EJEMAP, GSK, Former Director, Compliance, APAC, Abbott Labs, Delhi, India

Albert van Maaren, MSc
Regional Compliance Officer APAC, Group Compliance, Merck Pte. Ltd., Singapore

Katrina Reinhardt, JD
Regional Head Ethics and Compliance, Asia Pacific, Baxter Healthcare, Former Governance and Compliance Director, Greater China, Dow Corning, Singapore

Carol Shi
Compliance Director, Asia Area and ANZ, AstraZeneca, Singapore

Emmanuel Vignal
Partner and Greater China Leader, Fraud Investigation & Dispute Services, EY, Shanghai, China

Jonathan Shun Wah, PCLL
Senior Director, China Investigations Team Lead, Pfizer, Hong Kong

Chae Sing Wong
Former Head of Regional Compliance (APAC, MEA, LATM), Mundipharma Pte Ltd, Former Compliance Director, Asia, ANZ and Japan, Baxalta, Former Compliance Director Asia Area, AstraZeneca, Singapore

Hideki Yamanaka
Head of Ethics and Compliance, Japan and Vice President, Astellas Pharma, Tokyo, Japan

Xi Zhang, LLM, PhD Law
Vice President & General Counsel Greater China, Bayer (China) Limited, Former General Counsel Asia, Celanese, Shanghai, China

ASIA PACIFIC PHARMA CONGRESS IS


ONSITE ATTENDANCE
Simply register, travel to the conference city and attend in person.

Pros: subject matter immersion; professional networking opportunities; faculty interaction



PAST GLOBAL PHARMA COMPLIANCE CONGRESSES



2007 – Brussels


2008 – Paris


2009 – Rome


2010 – Berlin


2011 – Istanbul


2011 – Singapore


2012 – Budapest


2012 – Shanghai


2012 – São Paulo


2013 – Madrid


2013 – Kuala Lumpur


2014 – Dubai


2014 – Mexico City


2014 – Shanghai


2015 - Manila


2016 – Warsaw


2017 – Lisbon



We subscribe to the HONcode principles of the HON Foundation. Click to verify.




CONGRESS REGISTRATION
For Congress registration information, visit http://asianpharmacongress.com/registration/, email registration@hcconferences.com, or call 800-503-6498.

CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
For sponsorship and exhibit information visit http://asianpharmacongress.com/promotional-opportunities/, or contact Justin Sorensen, Exhibit Manager, 206-452-0609 phone, 206-319-5303 fax, exhibits@hcconferences.com.